1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:ROC curve analysis results for the prediction of response to induction chemotherapy based on the pretreatment tumor volume and the perfusion-associated parameters*
Response Cutoff Value Sensitivity (%) Specificity (%) AUC P Value Pretreatment tumor volume (mL) ≤15.3 100 (99.1–100) 33.3 (26.5–40.7) 0.50 .84 Blood flow (mL/100 g/min) ≤66.2 84.2 (79.8–89.7) 66.7 (59.3–73.5) 0.63 .0001 Blood volume (mL/100 g) >7.4 100 (98.9–100) 30.6 (23.9–37.8) 0.59 .0005 Mean transit time (s) <8.5 43.7 (38.4–49.1) 100 (98–100) 0.62 .0001 Permeability (mL/100 g/min) >8.6 65.4 (60.1–70.4) 100 (98–100) 0.78 .0001
Note:—AUC indicates area under the curve.
* The values (95% CI) represent thresholds above or below of which the patients will show a response.